Intraocular Melanoma Completed Phase 1 / 2 Trials for Thalidomide (DB01041)

Also known as: Intraocular melanoma NOS

IndicationStatusPhase
DBCOND0028574 (Intraocular Melanoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00005815Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV MelanomaTreatment